C. Seref Et Al. , "Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations," PROSTATE , vol.82, no.1, pp.145-153, 2022
Seref, C. Et Al. 2022. Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations. PROSTATE , vol.82, no.1 , 145-153.
Seref, C., Acar, O., Kilic, M., Vural, M., SAĞLICAN, Y., Sarac, H., ... Coskun, B.(2022). Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations. PROSTATE , vol.82, no.1, 145-153.
Seref, Ceren Et Al. "Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations," PROSTATE , vol.82, no.1, 145-153, 2022
Seref, Ceren Et Al. "Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations." PROSTATE , vol.82, no.1, pp.145-153, 2022
Seref, C. Et Al. (2022) . "Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations." PROSTATE , vol.82, no.1, pp.145-153.
@article{article, author={Ceren Seref Et Al. }, title={Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations}, journal={PROSTATE}, year=2022, pages={145-153} }